TenNor Therapeutics
PrivateLast Round
Series E
Oct 16, 2024
Total Funding Raised
$125.25M
Company Overview
TenNor Therapeutics is a biopharmaceutical company focused on developing innovative drugs for diseases related to bacterial infections and dysbiosis, offering a multi-targeting product development portfolio aimed at addressing gastrointestinal infections, medical device infections, and bacterial vaginosis to meet unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TenNor Therapeutics Comps
Public and private peers based on sector, stage, and business model.
TenNor Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Oct 16, 2024 | ||||
| Series D Extension | Dec 20, 2022 | ||||
| Series D | Mar 30, 2022 | ||||
| Series C | Oct 14, 2020 | ||||
| Series B | Sep 19, 2016 | ||||
Series A | Jul 9, 2013 |
TenNor Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AMR Action Fund | Series E |
| Yanchuang Capital | Series D, Series D Extension |
| Frontline BioVentures | Series B |
| Oriza Holdings | Series D |
| Relativity Healthcare Partners | Series B |
| Northern Light Venture Capital | Series B |
| Oriza Ventures | Series B |
TenNor Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TenNor Therapeutics's valuation, stock price, and market status.
